These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 28571579)

  • 1. How could we enhance translation of sepsis immunology to inform immunomodulation trials in sepsis?
    Shankar-Hari M
    Crit Care; 2017 May; 21(1):125. PubMed ID: 28571579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy in sepsis - brake or accelerate?
    Steinhagen F; Schmidt SV; Schewe JC; Peukert K; Klinman DM; Bode C
    Pharmacol Ther; 2020 Apr; 208():107476. PubMed ID: 31931100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immune system's role in sepsis progression, resolution, and long-term outcome.
    Delano MJ; Ward PA
    Immunol Rev; 2016 Nov; 274(1):330-353. PubMed ID: 27782333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunomodulation in sepsis: state of the art and future perspective.
    Antonopoulou A; Giamarellos-Bourboulis EJ
    Immunotherapy; 2011 Jan; 3(1):117-28. PubMed ID: 21174562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring immunomodulation in patients with sepsis.
    Kyriazopoulou E; Giamarellos-Bourboulis EJ
    Expert Rev Mol Diagn; 2021 Jan; 21(1):17-29. PubMed ID: 33183116
    [No Abstract]   [Full Text] [Related]  

  • 6. Modulating the inflammatory response in sepsis.
    Leitman IM
    J Surg Res; 2011 Dec; 171(2):e183-5. PubMed ID: 21962808
    [No Abstract]   [Full Text] [Related]  

  • 7. [Advances in sepsis induced immunosuppression and immunomodulation therapy].
    He X; Bo L; Jiang C
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Dec; 30(12):1202-1205. PubMed ID: 30592959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of treatments based on the cytokine storm theory of sepsis: time for a novel approach.
    Giamarellos-Bourboulis EJ
    Immunotherapy; 2013 Mar; 5(3):207-9. PubMed ID: 23444949
    [No Abstract]   [Full Text] [Related]  

  • 9. Balance Between the Proinflammatory and Anti-Inflammatory Immune Responses with Blood Transfusion in Sepsis.
    Rice TC; Pugh AM; Caldwell CC; Schneider BSP
    Crit Care Nurs Clin North Am; 2017 Sep; 29(3):331-340. PubMed ID: 28778292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of Sepsis-Induced Immunosuppression.
    Venet F; Rimmelé T; Monneret G
    Crit Care Clin; 2018 Jan; 34(1):97-106. PubMed ID: 29149944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic coordination of acute systemic inflammation: potential therapeutic targets.
    Vachharajani V; Liu T; McCall CE
    Expert Rev Clin Immunol; 2014 Sep; 10(9):1141-50. PubMed ID: 25088223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjunctive treatment of severe sepsis.
    Dinubile M
    Lancet Infect Dis; 2013 Nov; 13(11):917-8. PubMed ID: 24156894
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immune and inflammation confusion in severe sepsis and effects of bi-immunomodulation therapy: a prospective, randomized, controlled clinical trial].
    Zhou LX; Tan JJ; Li YN; Luo HT; Shao YH; Qiang XH; Yu TO; Ma MY; Mao KJ; Fang B
    Zhonghua Yi Xue Za Zhi; 2009 Apr; 89(15):1028-33. PubMed ID: 19595251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting macrophage immunometabolism: Dawn in the darkness of sepsis.
    Kumar V
    Int Immunopharmacol; 2018 May; 58():173-185. PubMed ID: 29625385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time-Series Expression of Toll-Like Receptor 4 Signaling in Septic Mice Treated with Mesenchymal Stem Cells.
    Wu KH; Wu HP; Chao WR; Lo WY; Tseng PC; Lee CJ; Peng CT; Lee MS; Chao YH
    Shock; 2016 Jun; 45(6):634-40. PubMed ID: 26682950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measures, markers, and mediators: toward a staging system for clinical sepsis. A report of the Fifth Toronto Sepsis Roundtable, Toronto, Ontario, Canada, October 25-26, 2000.
    Marshall JC; Vincent JL; Fink MP; Cook DJ; Rubenfeld G; Foster D; Fisher CJ; Faist E; Reinhart K
    Crit Care Med; 2003 May; 31(5):1560-7. PubMed ID: 12771633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sepsis-induced immunoparalysis: mechanisms, markers, and treatment options.
    Hamers L; Kox M; Pickkers P
    Minerva Anestesiol; 2015 Apr; 81(4):426-39. PubMed ID: 24878876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sepsis and scientific revolutions.
    Artenstein AW; Higgins TL; Opal SM
    Crit Care Med; 2013 Dec; 41(12):2770-2. PubMed ID: 23989175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term Host Immune Response Trajectories Among Hospitalized Patients With Sepsis.
    Yende S; Kellum JA; Talisa VB; Peck Palmer OM; Chang CH; Filbin MR; Shapiro NI; Hou PC; Venkat A; LoVecchio F; Hawkins K; Crouser ED; Newman AB; Angus DC
    JAMA Netw Open; 2019 Aug; 2(8):e198686. PubMed ID: 31390038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Immune System Regulation in Sepsis: From Innate to Adaptive.
    Qiu Y; Tu GW; Ju MJ; Yang C; Luo Z
    Curr Protein Pept Sci; 2019; 20(8):799-816. PubMed ID: 30843486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.